tiprankstipranks
Trending News
More News >
Unilever (GB:ULVR)
LSE:ULVR

Unilever (ULVR) AI Stock Analysis

Compare
699 Followers

Top Page

GB:ULVR

Unilever

(LSE:ULVR)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
,
Outperform 71 (OpenAI - 5.2)
,
Outperform 71 (OpenAI - 5.2)
,
Outperform 71 (OpenAI - 5.2)
,
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
5,054.00 p
▲(7.25% Upside)
Action:ReiteratedDate:02/18/26
The score is driven mainly by steady profitability and reliable free cash flow, tempered by higher leverage. Technicals are supportive (price above key averages, positive MACD) but appear overextended on RSI/Stoch. Valuation is somewhat demanding at ~22.7x earnings, while the ~3.44% dividend yield and earnings-call outlook (cautious growth guidance plus buyback and cash generation) provide support.
Positive Factors
Strong free cash flow
Consistent, high free cash flow and reported 100% cash conversion provide durable funding for dividends, buybacks and productivity reinvestment. This cash generation reduces reliance on external financing, supports deleveraging and gives management flexibility for strategic investments over multiple years.
Power Brands concentration
A concentrated portfolio of Power Brands driving majority revenue creates durable competitive advantage: stronger pricing power, higher marketing ROI and faster volume recovery. Prioritised investment behind these brands supports sustained market share gains and more predictable top-line performance over the medium term.
Margin expansion & productivity
Repeated margin expansion and a tracked productivity programme (target EUR 800m) indicate structural cost efficiency gains. Sustained delivery of productivity savings combined with targeted BMI improves gross and operating margins, enabling reinvestment behind growth while protecting profitability through input cost cycles.
Negative Factors
Elevated leverage
High leverage reduces financial flexibility and raises vulnerability to rate or earnings shocks. Even with recent net debt reduction and net debt/EBITDA ~2x, the capital structure leaves less room for large acquisitions or extended downturns and increases interest exposure, constraining strategic optionality.
Uneven revenue growth
Volatile top-line history signals exposure to portfolio swings, regional softness and demerger-related impacts. Irregular revenue trends complicate forecasting and capital allocation, and reliance on rebounds risks cyclical earnings variability unless non-Power Brand declines and portfolio transitions are fully stabilized.
FX, commodity & regional pressures
Persistent FX volatility and input-cost inflation in key commodities can structurally pressure gross margins and require ongoing price-cost recovery. Combined with regional demand weakness (e.g., Latin America volumes decline) this raises execution risk for margin targets and may force trade-offs between pricing, volume and market share.

Unilever (ULVR) vs. iShares MSCI United Kingdom ETF (EWC)

Unilever Business Overview & Revenue Model

Company DescriptionUnilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Personal Care, Foods & Refreshment, and Home Care segments. The Beauty & Personal Care segment provides skin care and hair care products, deodorants, and skin cleansing products. The Foods & Refreshment segment offers ice cream, soups, bouillons, seasonings, mayonnaise, ketchups, and tea categories. The Home Care segment provides fabric solutions and various cleaning products. The company offers its products under the Domestos, OMO, Seventh Generation, Ben & Jerry's, Knorr, Magnum, Wall's, Bango, the Vegetarian Butcher, Axe, Cif, Comfort, Dove, Lifebuoy, Lux, Rexona, Sunsilk, Equilibra, OLLY, Liquid I.V., SmartyPants, Onnit, Hellmann's, and Vaseline brands. Unilever PLC was incorporated in 1894 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyUnilever makes money primarily by selling branded consumer products to customers across multiple categories. Its core revenue model is product sales, where Unilever supplies goods (manufactured internally and/or through third-party manufacturers) into distribution channels and recognizes revenue from sales to retailers, wholesalers, distributors, and increasingly direct-to-consumer/e-commerce customers. Key revenue streams come from its major business groups: (1) Beauty & Wellbeing (e.g., haircare, skincare, and related products), (2) Personal Care (e.g., deodorants, body wash, oral care), (3) Home Care (e.g., laundry detergents, fabric care, household cleaning), and (4) Nutrition (e.g., cooking aids, condiments, and other foods). Earnings are influenced by a mix of factors including brand strength and pricing power, product mix (premium vs. value tiers), volume growth, geographic footprint across developed and emerging markets, input-cost management (commodities, packaging, logistics), and marketing effectiveness. Unilever also generates cash through efficiencies in its supply chain and scale benefits in procurement and manufacturing, while distribution partnerships with retailers, wholesalers, and e-commerce platforms help extend reach; specific partnership details beyond general channel relationships are null.

Unilever Earnings Call Summary

Earnings Call Date:Feb 12, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Jul 23, 2026
Earnings Call Sentiment Neutral
The call presents a broadly positive operational and strategic story: volume-led growth, Power Brands outperformance, margin expansion, strong cash generation, active portfolio reshaping and a clear capital allocation framework. However, significant near-term headwinds persist from currency, regional softness (notably Latin America and China for the year), pockets of underperformance (non-Power Brands, certain Hair Care and Prestige assets), demerger-related costs and selective commodity inflation. Management guidance for 2026 is cautious (bottom end of the 4-6% multiyear range, volumes at least 2% and modest margin improvement), reflecting both confidence in the transformation and recognition of continuing external risks.
Q4-2025 Updates
Positive Updates
Group underlying sales growth and quarter-on-quarter improvement
Underlying sales growth of 3.5% for FY2025 (volumes +1.5%, price +2.0%) with clear sequential improvement into Q4: Q4 underlying sales growth 4.2% (volumes +2.1%, price +2.0%).
Power Brands outperformance
30 Power Brands (>78% of turnover) delivered 4.3% underlying sales growth for the full year (volumes +2.2%) and 2-year CAGR of 5% (volumes 3.4%); Q4 Power Brands growth stepped up to 5.8% (volumes +3.5%).
Strong Beauty & Wellbeing and Personal Care performance
Beauty & Wellbeing: underlying sales growth +4.3% (volume +2.2%, price +2.1%), underlying operating profit EUR 2.5bn with margin 19.2% (down 20bps). Personal Care: sales +4.7%, underlying operating profit EUR 3.0bn and margin 22.6% (up 50bps), driven by U.S. momentum and premium innovations (e.g., Dove, Vaseline, Liquid I.V., Nutrafol).
Foods delivered record margins and solid growth
Foods underlying sales growth +2.5% (volume +0.8%, price +1.7%); underlying operating profit EUR 2.9bn and underlying operating margin 22.6%, up 130 basis points to the highest level for the business group.
Home Care recovery and improvements
Home Care full-year sales +2.6% (volume-led +2.2%, price +0.4%) with Q4 acceleration to +4.7% (volumes +4.0%); underlying operating profit EUR 1.7bn and margin 14.9% (up 40bps).
Emerging markets momentum and notable market turnarounds
Emerging markets (59% of turnover) grew +3.5% for the year with Q4 acceleration to +5.8% (volumes +3.2%). Asia Pacific & Africa: +4.6% FY (volumes +3.0%) and Q4 +6.9% (volumes +5.7%). India FY +4.0% (volumes +3.0%), Q4 +5.0% (volumes +4.0%). Indonesia showed marked recovery with Q4 growth of ~17%.
Margin expansion, gross margin improvement and productivity
Group underlying operating margin expanded by 60 basis points to 20.0%. Gross margin expanded by 20 basis points to 46.9% (third consecutive year of expansion). Overheads improved by 50 basis points. Productivity program delivered >EUR 670m savings, with EUR 800m target on track for 2026.
Strong cash generation and improved leverage
Free cash flow EUR 5.9bn (100% cash conversion); excluding demerger items free cash flow ~EUR 6.3bn. Net debt down EUR 1.4bn to EUR 23.1bn and net debt / underlying EBITDA ~2.0x.
Capital allocation and shareholder returns
Returned EUR 6.0bn to shareholders in 2025 (EUR 4.5bn dividends, EUR 1.5bn buybacks). Announced new share buyback of EUR 1.5bn for 2026 and continued commitment to growing dividends. 100% of incremental brand & marketing investment (BMI) deployed behind Power Brands; BMI increased to 16.1% of turnover (up 10bps).
Earnings resilience on a constant currency basis
Underlying EPS EUR 3.08, up 0.7% reported and up 9.5% on a constant currency basis after a significant FX headwind.
Negative Updates
Significant currency headwinds and reported turnover decline
Turnover EUR 50.5bn, down 3.8% versus prior year driven by FX which reduced turnover by 5.9%; on a constant currency basis turnover increased by 2.3%.
Reported underlying operating profit and EPS compression from FX
Underlying operating profit declined 1.1% to EUR 10.1bn. Reported underlying EPS rose only 0.7% to EUR 3.08 with currency having a negative ~8.8% impact on EPS.
Latin America weakness and volume declines
Latin America underlying sales +0.5% for the year but volumes declined by 5.1% (price +5.9%) reflecting weak consumer demand and macro/political headwinds; region only returned to growth in Q4.
China flat for the year
China underlying sales were flat for FY2025 (though with mid-single-digit improvement in H2/Q4); management notes more work required on go-to-market and premiumization.
Hair Care mixed performance and specific market issues
Overall Hair Care was flat for the year (pricing offset lower volumes). Specific performance gaps noted in U.S. and Brazil Hair businesses and some Home Care/Deodorant format issues in Brazil requiring corrective actions.
Non-Power Brands underperformance and portfolio pruning effects
Non-Power Brands (≈22% of revenue) saw volume decline of ~1% for the year and accelerated to ~-3% in Q4. Portfolio disposals and discontinuations contributed a net negative portfolio impact (-1.2% net; disposals -1.8%, acquisitions +0.6%).
Free cash flow reduction from demerger-related costs and TSA uncertainties
Free cash flow was ~EUR 400m lower versus prior year due to Ice Cream demerger costs (separation-related tax on disposals); TSA (transition services) receipts/costs from the Magnum separation not quantified externally, creating short-term cash/fee uncertainty.
Commodity and inflationary pressures concentrated in key inputs
Management expects select commodity inflation in 2026 (notably palm oil, canola oil and surfactants) and ongoing wage inflation in some markets, posing margin and pricing pressure in Home Care and Personal Care.
Prestige & certain portfolio areas need further execution
Prestige Beauty is mixed: standout growth for some brands (Hourglass, K18) but underperformance/decline and channel issues for others (Dermalogica professional channel, Paula's Choice) requiring brand relaunches and execution fixes.
Company Guidance
The company guided 2026 underlying sales growth at the bottom end of its 4–6% multiyear range (c.4%), with underlying volume growth of at least 2% and a “modest” further improvement to underlying operating margin (2025 margin: 20%); it expects overall inflation to be lower than 2025 but selective commodity pressure (palm, canola, surfactants), currency headwinds that are heavier in H1, and continued reinvestment into brands. Capital allocation guidance included a new €1.5bn share buyback, continued attractive/growing dividends (in principle a 70:30 dividend:buyback balance), CapEx around ~3% of turnover (3.1% in 2025) with ~55–60% focused on productivity/margin initiatives, completion of the €800m productivity program (€670m delivered in 2025 with ~€130m remaining in 2026), and a commitment to strong cash generation/100% cash conversion and a balanced capital structure (net debt/EBITDA ~2x).

Unilever Financial Statement Overview

Summary
Profitability and free cash flow are solid (income statement 74; cash flow 71), supporting resilience and earnings quality. The main constraint is elevated leverage (balance sheet 58), which reduces flexibility if conditions weaken, and revenue growth has been uneven.
Income Statement
74
Positive
Profitability is solid and fairly resilient, with EBIT margin generally in the mid-to-high teens and net margin mostly around ~9%–13% (2025 net margin ~12.1%). Revenue growth has been uneven (declines in 2020 and 2023, modest growth in 2024, and a sharp rebound in 2025), which adds volatility to the topline outlook. A key data gap is 2025 gross profit and gross margin shown as 0, limiting visibility into the latest year’s product cost pressure vs. pricing power.
Balance Sheet
58
Neutral
Leverage is the main constraint: debt-to-equity is consistently elevated (roughly ~1.5–1.9), with 2025 at the high end (~1.91) alongside lower equity versus prior years, reducing balance-sheet flexibility. Total assets are stable, but the capital structure leans heavily toward debt financing, which can amplify risk if earnings weaken or rates stay higher. Strength is that profitability has been strong historically (return on equity was high in 2020–2024), though 2025 return on equity is not provided.
Cash Flow
71
Positive
Cash generation is consistently positive, with free cash flow running at a healthy portion of earnings (free cash flow to net income ~0.78–0.90 across years; 2025 ~0.82), indicating earnings quality is generally good. Free cash flow growth is volatile (notably down in 2021–2022 and 2024, then up in 2025), which suggests periodic working-capital swings or reinvestment variability. Operating cash flow relative to EBIT is moderate (~0.29–0.44), implying cash conversion is decent but not exceptionally strong.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue49.59B60.76B59.60B60.07B52.44B
Gross Profit23.28B27.37B25.18B24.17B22.18B
EBITDA11.11B11.74B11.99B13.07B10.82B
Net Income5.99B5.74B6.49B7.64B6.05B
Balance Sheet
Total Assets70.56B79.75B75.27B77.82B75.09B
Cash, Cash Equivalents and Short-Term Investments5.07B7.63B6.11B5.52B4.50B
Total Debt29.64B30.66B28.59B28.44B29.67B
Total Liabilities52.95B57.20B54.50B56.12B55.35B
Stockholders Equity15.55B19.99B18.10B19.02B17.11B
Cash Flow
Free Cash Flow6.39B7.55B7.68B5.66B6.73B
Operating Cash Flow7.78B9.52B9.43B7.28B7.97B
Investing Cash Flow-3.65B-625.00M-2.29B2.45B-3.25B
Financing Cash Flow-5.69B-6.94B-7.19B-8.89B-7.10B

Unilever Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4712.50
Price Trends
50DMA
5019.17
Negative
100DMA
200DMA
Market Momentum
MACD
-92.33
Positive
RSI
29.13
Positive
STOCH
23.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ULVR, the sentiment is Negative. The current price of 4712.5 is below the 20-day moving average (MA) of 5100.96, below the 50-day MA of 5019.17, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -92.33 indicates Positive momentum. The RSI at 29.13 is Positive, neither overbought nor oversold. The STOCH value of 23.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ULVR.

Unilever Risk Analysis

Unilever disclosed 14 risk factors in its most recent earnings report. Unilever reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Unilever Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
£1.62B8.9510.71%1.62%0.50%20.52%
71
Outperform
£102.98B20.3328.78%3.85%-2.98%-16.90%
69
Neutral
£13.10B15.479.22%2.98%-3.06%-26.93%
66
Neutral
£31.73B5.9819.40%5.00%-2.83%-40.42%
66
Neutral
£34.33B12.3038.45%3.44%-2.41%-16.41%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
£308.75M14.34-2.16%4.82%-2.67%89.86%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ULVR
Unilever
4,574.00
-236.15
-4.91%
GB:DGE
Diageo
1,402.00
-619.67
-30.65%
GB:ABF
Associated British Foods
1,802.50
-65.57
-3.51%
GB:PFD
Premier Foods
184.40
3.18
1.75%
GB:PZC
PZ Cussons
71.40
-4.58
-6.02%
GB:RKT
Reckitt
5,138.00
139.87
2.80%

Unilever Corporate Events

Executive/Board ChangesFinancial DisclosuresRegulatory Filings and Compliance
Unilever Files 2025 Annual Report and Delays New Board Appointment to 2027
Neutral
Mar 12, 2026

Unilever has published its 2025 Annual Report and Accounts and its 2025 Form 20-F, making the documents available on its website and through key regulatory channels in the UK, the Netherlands and the U.S. The filings, covering the year ended 31 December 2025, reinforce the group’s compliance with multi-jurisdictional reporting standards and provide investors with detailed insight into its financial performance, risks and governance.

The company also updated the market on governance changes, confirming that the appointment of Belén Garijo López as an independent non-executive director to the Unilever board, first announced in October 2025, is now expected to take effect during 2027. This delay in a planned board addition may draw attention from governance-focused investors, though Unilever’s reiteration of its risk disclosures and regulatory transparency underlines its efforts to maintain confidence among stakeholders across its major listing venues.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4300.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Unilever Grants Performance Share Awards to Senior Leadership
Positive
Mar 10, 2026

Unilever has disclosed a series of performance share plan (PSP) awards in the form of ordinary shares and ADRs granted to several members of its leadership executive, including business group presidents, the chief R&D officer, and the CEO of Hindustan Unilever. The awards, executed outside a trading venue on 6 March 2026 in multiple currencies, underline the company’s continued use of equity-based incentives to align senior management compensation with shareholder interests and long‑term value creation across its global operations.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4300.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Discloses Share Sale by Foods Division President
Neutral
Mar 6, 2026

Unilever has disclosed a share transaction by Heiko Schipper, Business Group President, Foods and a member of the Unilever Leadership Executive. Schipper sold 2,600 Unilever PLC ordinary shares on 6 March 2026 on the Amsterdam Stock Exchange at a price of €58.03 per share, for a total value of €150,872.37.

The transaction, reported under regulatory requirements for persons discharging managerial responsibilities, provides transparency around insider dealings in Unilever stock. While routine in nature, such disclosures are closely watched by investors for potential signals on executive confidence and alignment with shareholder interests.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4300.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Discloses Share Sale by Foods Division President
Neutral
Mar 6, 2026

Unilever disclosed that Heiko Schipper, Business Group President for Foods and a member of the Unilever Leadership Executive, sold 2,600 Unilever PLC ordinary shares on 6 March 2026. The transaction, executed on the Amsterdam Stock Exchange at a price of €58.03 per share for a total value of €150,872.37, was reported as required for dealings by persons discharging managerial responsibilities, providing transparency for investors and regulators.

The share sale forms part of routine regulatory disclosures of insider transactions and does not in itself signal a change in Unilever’s strategic direction or operational outlook. However, such dealings by senior executives are closely watched by the market as potential indicators of management’s confidence and can influence investor sentiment toward the company’s stock in the short term.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4300.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Updates Share Capital and Voting Rights for Investors
Neutral
Mar 2, 2026

Unilever PLC has provided an update on its voting rights and capital structure as of 27 February 2026, confirming an issued share capital of 2,185,205,247 ordinary shares with no treasury shares held. Of these, 256,281 shares are held within the Unilever group and carry no exercisable voting rights, leaving 2,184,948,966 shares with voting rights, a key reference figure for investors.

The company stated that shareholders should use the 2,184,948,966 figure as the denominator when assessing whether changes in their holdings trigger disclosure obligations under UK financial transparency rules. This clarification helps maintain compliance with regulatory requirements and offers investors precise data for monitoring their reportable stakes in Unilever PLC.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4300.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Executive/Board Changes
Unilever Names Prakash Kakkad Chief Legal Officer and Group Company Secretary
Positive
Mar 2, 2026

Unilever PLC has appointed Prakash Kakkad as its new Chief Legal Officer and Group Company Secretary, effective 1 March 2026. He will also join the Unilever Leadership Executive, underscoring the strategic importance of the legal and governance function within the group and signalling continuity in senior leadership following the departure of Maria Varsellona.

The leadership change places Kakkad at the centre of Unilever’s legal, compliance, and corporate governance agenda, which is critical for a global consumer goods group operating in multiple regulatory environments. His role on the top executive team may shape how Unilever navigates litigation risk, regulatory scrutiny, and governance expectations from investors and other stakeholders.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4300.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Discloses £1 Million Share Sale by R&D Chief Richard Slater
Neutral
Feb 19, 2026

Unilever PLC disclosed that Chief Research & Development Officer Richard Slater, a member of the Unilever Leadership Executive, has carried out a share transaction involving the company’s ordinary shares. The notification forms part of regulatory requirements for reporting dealings by senior management and provides transparency to investors about insider transactions.

According to the filing, Slater sold 18,486 Unilever PLC ordinary 3.5 pence shares on 17 February 2026 on the London Stock Exchange at a price of £54.137945 per share, for a total value of about £1.0 million. The transaction highlights ongoing equity dealings by top executives and may be monitored by shareholders assessing management’s confidence and personal exposure to Unilever’s stock.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £6035.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Executive/Board ChangesRegulatory Filings and Compliance
Unilever Details Vesting of Performance Share Awards to Senior Leaders
Neutral
Feb 16, 2026

Unilever has disclosed a series of share awards vesting to senior executives under its performance share plan, reinforcing equity-based compensation as a core element of leadership pay. Chief Financial Officer Srinivas Phatak, several Unilever Leadership Executive members, and the CEO and Managing Director of Hindustan Unilever received vested ordinary shares or ADRs, in transactions dated 12 February and executed outside a trading venue.

The vesting, which spans home care, personal care, R&D, legal and the India business, aligns top management interests more closely with shareholders and signals ongoing use of long-term incentive structures. While the announcement is largely administrative, it underlines Unilever’s governance practice of publicly reporting transactions by persons discharging managerial responsibilities, an area closely watched by investors assessing alignment and potential signalling effects.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £60.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Executive/Board ChangesRegulatory Filings and Compliance
Unilever Discloses Vesting of Performance Share Awards to Senior Executives
Neutral
Feb 16, 2026

Unilever has disclosed multiple share transactions involving members of its senior leadership, following the vesting of performance share plan (PSP) awards in both London-listed ordinary shares and U.S.-traded ADRs. Executives including CFO Srinivas Phatak, Home Care President Eduardo Campanella, Chief R&D Officer Richard Slater, Chief Legal Officer Maria Varsellona, Hindustan Unilever CEO Priya Nair and Personal Care President Fabian Garcia all received shares off-market on 12 February, underscoring the company’s continued use of share-based remuneration to tie leadership compensation to equity performance and regulatory transparency requirements for PDMR dealings.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £60.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Executive/Board Changes
Unilever Discloses Expanded External Role for Senior Independent Director Susan Kilsby
Neutral
Feb 13, 2026

Unilever PLC disclosed a change in external responsibilities for one of its senior board members, underlining the continued prominence of its directors in international corporate leadership. The company reported that non-executive director Susan Kilsby, who also serves as Vice Chair and Senior Independent Director, is assuming expanded duties at another listed business.

Kilsby will become Executive Chair of Fortune Brands Innovations from 12 February 2026 and temporarily take on the functions of Chief Executive Officer between 1 April and 13 May 2026 during a defined transition period. Following that window, she will revert to her prior role as Chair of Fortune Brands Innovations, while retaining her existing non-executive and oversight responsibilities at Unilever, indicating continuity in Unilever’s board composition and governance structure.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £60.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Private Placements and FinancingRegulatory Filings and Compliance
Unilever Updates Documentation for U.S.$25 Billion Debt Issuance Programme
Neutral
Feb 12, 2026

Unilever has published a new FCA-approved supplement to its U.S.$25 billion debt issuance programme, covering Unilever Finance Netherlands B.V., Unilever Capital Corporation, and Unilever PLC as issuers, with Unilever PLC and Unilever United States, Inc. acting as guarantors. The supplement, which updates the existing information memorandum and related documentation for investors, underscores Unilever’s continued use of large-scale debt facilities as a financing tool, helping maintain flexibility in its capital structure and access to funding markets.

The updated documents have been made available via the London Stock Exchange’s document service and will also be stored in the FCA’s National Storage Mechanism for public inspection. This transparency in updating and filing programme documentation supports regulatory compliance and provides bond investors with current information on Unilever’s financing framework and related terms.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4100.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsFinancial DisclosuresM&A Transactions
Unilever lifts margins and reshapes portfolio as Ice Cream demerger completes
Positive
Feb 12, 2026

Unilever reported 2025 underlying sales growth of 3.5% driven by a 1.5% rise in volumes, resilient margins and strong contributions from its Power Brands, even as headline turnover declined due to currency headwinds and disposals. The group expanded its underlying operating margin to 20.0%, lifted earnings, generated robust free cash flow and raised its dividend while announcing a €1.5 billion share buyback.

Management accelerated portfolio reshaping by completing the demerger of the Ice Cream business and executing ten portfolio transactions, increasing exposure to Beauty & Wellbeing and Personal Care and exiting non-core food assets. Operational changes, including category-led sales structures and resets in Indonesia and China, underpinned stronger emerging-market performance and support guidance for modestly higher margins and low-end-of-range sales growth in 2026 despite slower markets.

The most recent analyst rating on (GB:ULVR) stock is a Hold with a £5150.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Business Operations and Strategy
Unilever Issues 4.2 Million New Shares to Satisfy Employee Share Awards
Neutral
Feb 5, 2026

Unilever PLC has issued and allotted 4,200,000 new ordinary shares of 3½ pence each to satisfy the vesting of awards under its employee share schemes, including the Unilever Share Plan 2017, the Unilever North America Omnibus Equity Compensation Plan, and the SHARES Plan. These new shares, admitted to trading on the London Stock Exchange’s Main Market under an existing block admission dated 14 March 2024, are fully fungible and will rank equally with the company’s existing ordinary shares, bringing the total number of issued ordinary shares to 2,185,205,247 and leaving 1,577,778 ordinary shares remaining under the block admission for future issuance.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £57.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Updates Share Capital and Voting Rights for Disclosure Purposes
Neutral
Feb 2, 2026

Unilever PLC has reported that, as of 30 January 2026, its issued share capital comprised 2,181,005,247 ordinary shares, of which 314,912 shares were held by Unilever group companies and carry no exercisable voting rights, leaving 2,180,690,335 shares with voting rights. The company stated that this voting-share figure should be used by investors as the reference denominator for calculating and disclosing their holdings or changes in holdings under UK disclosure and transparency rules, underscoring Unilever’s compliance with regulatory requirements and providing clarity for shareholders on the current voting rights base.

The most recent analyst rating on (GB:ULVR) stock is a Hold with a £5135.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Corrects Total Voting Rights Figure After Reporting Error
Neutral
Jan 8, 2026

Unilever PLC has issued a correction to its earlier disclosure on total voting rights, clarifying that as of 31 December 2025 the group held 314,912 ordinary shares (including those represented by ADSs), not 319,412 as previously stated. The company confirmed its issued share capital at 2,181,005,247 ordinary shares of 3.5p each, with no treasury shares and 2,180,690,335 shares carrying exercisable voting rights, a figure that shareholders should now use as the denominator for regulatory notifications of holdings under UK disclosure rules.

The most recent analyst rating on (GB:ULVR) stock is a Sell with a £4100.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Regulatory Filings and Compliance
Unilever Updates Share Capital and Voting Rights Ahead of FCA Disclosure Calculations
Neutral
Jan 2, 2026

Unilever PLC reported that as of 31 December 2025 its issued share capital comprised 2,181,005,247 ordinary shares, of which 319,412 were held by or on behalf of Unilever group companies and carry no exercisable voting rights, leaving 2,180,685,835 shares with voting rights outstanding. The company noted that this voting share figure will serve as the reference denominator for shareholders when calculating whether they must disclose their holdings or changes in holdings under UK Financial Conduct Authority transparency rules, providing clarity for investors and regulators on Unilever’s current capital and voting rights structure.

The most recent analyst rating on (GB:ULVR) stock is a Buy with a £5200.00 price target. To see the full list of analyst forecasts on Unilever stock, see the GB:ULVR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026